Literature DB >> 3209328

Family history of autoimmune disorders and cancer in multiple myeloma.

M S Linet1, J K Mclaughlin, S D Harlow, J F Fraumeni.   

Abstract

To explore genetic mechanisms that might underlie the relation observed between multiple myeloma and rheumatoid arthritis, we examined the occurrence of autoimmune disorders in first-degree relatives of myeloma cases and controls. There was a significant excess of rheumatoid arthritis (OR = 3.7; 95% CI = 1.0-13.1) among the relatives of cases compared with controls, as well as an increased occurrence of systemic lupus erythematosus and pernicious anaemia. An excess of certain cancers was also observed among family members, including leukaemia and cancers of the breast, endometrium, and oral cavity and pharynx, but none of the excesses were significant. These findings deserve further evaluation in larger population-based studies.

Entities:  

Mesh:

Year:  1988        PMID: 3209328     DOI: 10.1093/ije/17.3.512

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  9 in total

Review 1.  Inherited genetic susceptibility to multiple myeloma.

Authors:  G J Morgan; D C Johnson; N Weinhold; H Goldschmidt; O Landgren; H T Lynch; K Hemminki; R S Houlston
Journal:  Leukemia       Date:  2013-11-19       Impact factor: 11.528

Review 2.  FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature.

Authors:  Milica Čolović; Vladimir Jurisic; Jelena Bila; Natasa Čolović; Vuk Palibrk
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

3.  Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study.

Authors:  M Eriksson; B Hållberg
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

4.  Non-lymphoma hematological malignancies in systemic lupus erythematosus.

Authors:  Mary Lu; Sasha Bernatsky; Rosalind Ramsey-Goldman; Michelle Petri; Susan Manzi; Murray B Urowitz; Dafna Gladman; Paul R Fortin; Ellen M Ginzler; Edward Yelin; Sang-Cheol Bae; Daniel J Wallace; Soren Jacobsen; Mary Anne Dooley; Christine A Peschken; Graciela S Alarcón; Ola Nived; Lena Gottesman; Lindsey A Criswell; Gunnar Sturfelt; Lene Dreyer; Jennifer L Lee; Ann E Clarke
Journal:  Oncology       Date:  2013-10-02       Impact factor: 2.935

5.  Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.

Authors:  Ola Landgren; Eric A Engels; Neil E Caporaso; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Martha S Linet; Lynn R Goldin
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

6.  Medical history and the risk of multiple myeloma.

Authors:  A Gramenzi; I Buttino; B D'Avanzo; E Negri; S Franceschi; C La Vecchia
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

Review 7.  The role of genetic factors in autoimmune disease: implications for environmental research.

Authors:  G S Cooper; F W Miller; J P Pandey
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

8.  Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects.

Authors:  Helen H McDuffie; Punam Pahwa; Chandima P Karunanayake; John J Spinelli; James A Dosman
Journal:  BMC Cancer       Date:  2009-02-27       Impact factor: 4.430

Review 9.  Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Alexei Shimanovsky; Juliana Alvarez Argote; Shruti Murali; Constantin A Dasanu
Journal:  BBA Clin       Date:  2016-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.